Sign Up Today and Learn More About Rani Therapeutics Stock
Invest in or calculate the value of your shares in Rani Therapeutics or other pre-IPO companies through EquityZen's platform.
Rani Therapeutics Stock
Rani Therapeutics develops bio-therapeutics technology for the oral delivery of large drug molecules.
About Rani Therapeutics Stock
Founded
2012
Headquarters
San Jose, CA, US
Total Funding
143M
Industries
Science and Engineering, Health Care, Biotechnology
Rani Therapeutics, LLC develops a oral biotherapeutics technology for the oral delivery of large drug molecules, including peptides, proteins, and antibodies. The company is based in San Jose, California.
Rani Therapeutics Management
Leadership team at Rani Therapeutics
Vice President, Finance & Operations
Syed Zaidi
Vice President, Research & Development
Mir Hashim
Join now and verify your accreditation status to gain access to:
- Rani Therapeutics Current Valuation
- Rani Therapeutics Stock Price
- Rani Therapeutics Management
- Available deals in Rani Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Rani Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Rani Therapeutics Revenue and Financials
- Rani Therapeutics Highlights
- Rani Therapeutics Business Model
- Rani Therapeutics Risk Factors
- Rani Therapeutics Research Report from SACRA Research
Trading Rani Therapeutics Stock
How to invest in Rani Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Rani Therapeutics through EquityZen funds. These investments are made available by existing Rani Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Rani Therapeutics stock?
Shareholders can sell their Rani Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."